Research company Oncopeptides will participate in the 23rd annual meeting of the International Myeloma Society, IMS, which takes place in Glasgow, Scotland, from 23 to 26 September. This is stated in a press release.
Oncopeptides will highlight clinical advances and present new data at the meeting.
